This story has been updated from a previous version.

NEW YORK, May 31 – Roche said Thursday it would appeal the European Patent Office’s decision to revoke Roche’s patent for a number of enzymes, including Taq DNA polymerase, a staple in conducting PCR and gene sequencing.

“We will appeal this ruling because it is incorrect,” a Roche spokeswoman said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.